Identification of complement factor H variants that predispose to pre‐eclampsia: A genetic and functional study
BJOG: An International Journal of Obstetrics & Gynaecology · 2023-11 · 130 (12) · 1473-1482
DOI: 10.1111/1471-0528.17529 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 08.05.2023. Verfasst von A Inkeri Lokki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Research Program, Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Complement Factor H, Pre-Eclampsia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Objective
The objective of the study was to investigate the role of genetic variants in complement proteins in pre‐eclampsia.
Design
In a case–control study involving 609 cases and 2092 controls, five rare variants in complement factor H ( CFH ) were identified in women with severe and complicated pre‐eclampsia. No variants were identified in controls.
Setting
Pre‐eclampsia is a leading cause of maternal and fetal morbidity and mortality. Immune maladaptation, in particular, complement activation that disrupts maternal‐fetal tolerance leading to placental dysfunction and endothelial injury, has been proposed as a pathogenetic mechanism, but this remains unproven. Population We genotyped 609 pre‐eclampsia cases and 2092 controls from FINNPEC and the national FINRISK cohorts.
Methods
Complement‐based functional and structural assays were conducted in vitro to define the significance of these five missense variants and each compared with wild type. Main outcome measures Secretion, expression and ability to regulate complement activation were assessed for factor H proteins harbouring the mutations.
Results
We identified five heterozygous rare variants in complement factor H (L3V, R127H, R166Q, C1077S and N1176K) in seven women with severe pre‐eclampsia. These variants were not identified in controls. Variants C1077S and N1176K were novel. Antigenic, functional and structural analyses established that four (R127H, R166Q, C1077S and N1176K) were deleterious. Variants R127H and C1077S were synthesised, but not secreted. Variants R166Q and N1176K were secreted normally but showed reduced binding to C3b and consequently defective complement regulatory activity. No defect was identified for L3V.
Conclusions
These results suggest that complement dysregulation due to mutations in complement factor H is among the pathophysiological mechanisms underlying severe pre‐eclampsia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology Research Program, Bacteriology and Immunology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Heart and Lung Centre, Helsinki University Hospital, Helsinki, Finland.
- Division of Clinical Immunology and Allergy, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
- Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: A Inkeri Lokki
Förderung
- NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- Academy of Finland
- Alfred Kordelinin Säätiö
- Jane ja Aatos Erkon Säätiö
- National Institutes of Health
- Sigrid Juséliuksen Säätiö
Zitieren
APA
Lokki, A. I., Ren, Z., Triebwasser, M., Daly, E., FINNPEC, Perola, M., Auro, K., Burwick, R., Salmon, J. E., Daly, M., Laivuori, H., Atkinson, J. P., Java, A., & Meri, S. (2023). Identification of complement factor H variants that predispose to pre‐eclampsia: A genetic and functional study. BJOG: An International Journal of Obstetrics & Gynaecology, 130(12), 1473-1482. https://doi.org/10.1111/1471-0528.17529
Vancouver
Lokki AI, Ren Z, Triebwasser M, Daly E, FINNPEC, Perola M, et al. Identification of complement factor H variants that predispose to pre‐eclampsia: A genetic and functional study. BJOG: An International Journal of Obstetrics & Gynaecology. 2023;130(12):1473-1482. doi:10.1111/1471-0528.17529
BibTeX
@article{Lokki2023,
author = {Lokki, A Inkeri and Ren, Zhen and Triebwasser, Michael and Daly, Emma and FINNPEC, FINNPEC and Perola, Markus and Auro, Kirsi and Burwick, Richard and Salmon, Jane E and Daly, Mark and Laivuori, Hannele and Atkinson, John P and Java, Anuja and Meri, Seppo},
title = {Identification of complement factor H variants that predispose to pre‐eclampsia: A genetic and functional study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2023},
volume = {130},
number = {12},
pages = {1473--1482},
doi = {10.1111/1471-0528.17529}
}
EUVIMED